Vermont Senate advances bill to authorize Burlington pilot for overdose prevention centers

The Vermont Senate on the floor advanced H72, a bill that would create a statutory framework for overdose prevention centers (OPCs), authorize a pilot project in Burlington and require detailed reporting and independent evaluation. The chamber ordered the bill to third reading after recorded votes on committee amendments and other changes.

Senate Health and Welfare’s reporter, identified in the transcript as the "Senator from Chittenden Southeast," told colleagues the measure responds to a rising number of overdose deaths in the state and to peer‑reviewed research. "These are preventable deaths," the senator said. "This is an unacceptable trajectory." The reporter said H72 would provide immunity protections for OPC participants, staff and certain host entities that operate within Department of Health guidelines, and would require the Department to publish operating guidelines by Sept. 15, 2024.

Why it matters: H72 would create a legal and operational path for a supervised site in Burlington where people can use drugs under medical supervision, with staff able to administer emergency care and refer participants to treatment. Proponents say OPCs save lives, reduce public syringe litter and connect people to services; opponents warn of community risks, uncertain implementation details and constitutional and federal‑law questions.

Key provisions and funding
- Statutory protections and limits: The bill sets criteria for OPCs, outlines criminal and civil immunity for individuals and staff acting within the statute and Department of Health guidelines, and clarifies that immunity does not prevent prosecutors from using independently obtained evidence.
- Guidelines: The Department of Health must consult stakeholders and jurisdictions with existing OPCs and publish operating guidelines by Sept. 15, 2024, including minimum staff qualifications and basic medical response capabilities such as CPR and overdose interventions.
- Pilot and appropriation: H72 authorizes a Burlington pilot and appropriates $1,100,000 in 2025 from the Opioid Abatement Special Fund to award grants to the city upon submission of an approved municipal grant proposal. The bill requires quarterly reporting to the Joint Fiscal Committee and a four‑year independent study with interim annual reports (due Jan. 15 each year) and a final report by Jan. 15, 2029.

Supporters and evidence
Supporters cited research and testimony gathered in committee and elsewhere. The reporter summarized submissions from the Vermont Medical Society, the American Medical Association, the American Society of Addiction Medicine, local mayors (including Burlington’s current and former mayors), academic researchers and harm‑reduction organizations. "OPCs are a tool that will save lives," said Senator Madison in floor remarks, noting personal and community losses and urging the chamber to adopt a public‑health approach.

The reporter also cited international and domestic precedents, pointing to evaluations of OPCs in Canada, Europe and New York City and asserting, "We've seen that these centers work to both save lives in the moment and save lives long term. There's never been a fatal overdose in the history of an OPC worldwide," language used on the floor when summarizing global evaluations.

Opposition and legal, operational concerns
Opponents questioned whether Vermont has the infrastructure and community supports to operate OPCs safely statewide or even in a single pilot. One senator said he would vote no, citing concern that Vermont's "toolbox" is not ready for the facility and warned of potential increases in local drug activity and unclear liability rules.

Floor debate highlighted specific concerns:
- Age limits and youth access: An amendment proposing to restrict full OPC services to those 21 and older was debated at length; supporters of the amendment argued it would protect youth, while opponents said it could deny lifesaving care to at‑risk young people. The Health and Welfare committee voted 3–2 not to adopt the age‑21 restriction and the floor amendment subsequently failed.
- Immunity scope: A three‑member Judiciary amendment, adopted on the floor, clarifies that civil immunity would not shield an individual who leaves an OPC and then commits a DUI and that immunity does not apply to claims unrelated to the provision of OPC services.
- Federal law and prosecutorial exposure: Senators noted that federal statutes still prohibit possession and distribution and raised questions about how state‑level immunity interacts with federal enforcement; the reporter acknowledged federal law is not changed by H72.

Next steps and procedural status
The Senate conducted a roll‑call vote on ordering third reading; the presiding officer announced the result as 21 yeas and 8 nays, and H72 was ordered to third reading. If it advances and is enacted, the Department of Health would publish operational guidelines and oversight would include quarterly fiscal reporting and an independent evaluation with interim annual reports through 2029.

What remains unresolved: Several implementation details depend on forthcoming Department of Health guidelines — including entry controls, age‑related procedures and staff training — and senators asked for those specifics to be developed in consultation with local public safety, clinical providers and community stakeholders.

Attribution: Quotations and factual summaries in this report are taken from floor remarks by the Senate reporter for Health and Welfare (identified in the transcript as "Senator from Chittenden Southeast") and from senators who spoke on the floor during the H72 debate.